182 related articles for article (PubMed ID: 35792657)
1. Novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression.
Luo QY; Di T; Chen ZG; Peng JH; Sun J; Xia ZF; Pan WT; Luo F; Lu FT; Sun YT; Yang LQ; Zhang L; Qiu MZ; Yang DJ
Cancer Sci; 2022 Oct; 113(10):3330-3346. PubMed ID: 35792657
[TBL] [Abstract][Full Text] [Related]
2. High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma.
Luo QY; Di T; Qiu MZ; Xia ZF; Du Y; Lin RD; Yang LQ; Sun YT; Yang DJ; Sun J; Zhang L
Cancer Cell Int; 2022 Feb; 22(1):90. PubMed ID: 35189899
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y
Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
5. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
Front Immunol; 2022; 13():881359. PubMed ID: 35911752
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract][Full Text] [Related]
7. Identification of an alternative splicing signature as an independent factor in colon cancer.
Chen H; Luo J; Guo J
BMC Cancer; 2020 Sep; 20(1):904. PubMed ID: 32962686
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
9. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
11. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li J; Xiao Y
Biomed Res Int; 2020; 2020():8896511. PubMed ID: 33195699
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
14. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
17. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
Zhang Q; Feng Z; Zhang Y; Shi S; Zhang Y; Ren S
Biomed Res Int; 2021; 2021():6057948. PubMed ID: 34124251
[TBL] [Abstract][Full Text] [Related]
18. A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis.
Lu Z; Chen J; Yan J; Liu Q; Li F; Xiong W; Lin S; Yu K; Liang J
Comb Chem High Throughput Screen; 2021; 24(8):1205-1216. PubMed ID: 32998675
[TBL] [Abstract][Full Text] [Related]
19. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
Fang Z; Xu S; Xie Y; Yan W
World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer.
Zhou L; Mei J; Cao R; Liu X; Fu B; Ma M; Gong B; Luo L; Liu Y; Zhu Q; Meng X
Aging (Albany NY); 2023 Sep; 15(17):8851-8872. PubMed ID: 37683130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]